ImmunoPrecise Antibodies ... (IPA)
NASDAQ: IPA
· Real-Time Price · USD
2.71
0.71 (35.50%)
At close: Aug 18, 2025, 3:59 PM
2.71
0.00%
After-hours: Aug 18, 2025, 07:19 PM EDT
35.50% (1D)
| Bid | 2.7 |
| Market Cap | 125.08M |
| Revenue (ttm) | 24.52M |
| Net Income (ttm) | -30.23M |
| EPS (ttm) | -0.66 |
| PE Ratio (ttm) | -4.11 |
| Forward PE | -13.47 |
| Analyst | Buy |
| Ask | 2.8 |
| Volume | 9,527,773 |
| Avg. Volume (20D) | 2,531,266 |
| Open | 2.02 |
| Previous Close | 2.00 |
| Day's Range | 2.00 - 2.72 |
| 52-Week Range | 0.27 - 2.72 |
| Beta | 0.55 |
Analyst Forecast
According to 0 analyst ratings, the average rating for IPA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
ImmunoPrecise Antibodies Ltd. is scheduled to release its earnings on
Sep 15, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
-14.36%
ImmunoPrecise Antibodies shares are trading lower ...
Unlock content with
Pro Subscription
3 weeks ago
+26.92%
ImmunoPrecise Antibodies shares are trading higher after the company announced positive results from a newly expanded study for lensai immunogenicity screening.
2 weeks ago · fool.com
ImmunoPrecise (IPA) Q4 2025 Earnings TranscriptImage source: The Motley Fool.
1 month ago · businesswire.com
ImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price RequirementAUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a company operating at the convergence of TechBio and biological intelligence, today ...